Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
*Compounded medications are not evaluated by the FDA for safety or efficacy
This low initial dose is a tolerability phase, as it allows the body to adjust to GLP-1 signaling and reduces the risk of nausea and other gastrointestinal side effects before doses are increased
European Association for the Study of Diabetes (EASD) 60th Annual Meeting
GLP-1 receptor agonists mimic the incretin hormone GLP-1
Tirzepatide is a once-weekly injectable medication, FDA-approved under the brand name Mounjaro to treat type 2 diabetes and FDA-approved under the brand name Zepbound for weight loss
US$ 26.38
US$ 25.05
US$ 25.29
US$ 25.77
US$ 20.58
